<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="8684" id="root" date="1996-08-22" xml:lang="en">
<title>USA: RESEARCH ALERT - Dura estimates raised.</title>
<headline>RESEARCH ALERT - Dura estimates raised.</headline>
<text>
<p>--Vector Securities International analyst Peter Ginsberg said he raised his fiscal 1997 earnings estimate for Dura Pharmaceuticals Inc to $0.87 per share from $0.66, and raised his 1998 estimate to $1.17 from $0.83.</p>
<p>--Shares in the San Diego-based drug concern were up 5-1/4 to 32 after Dura said it would buy the marketing rights to two antibiotics -- Ceclor CD and Keftab -- from Eli Lilly and Co for $100 million.</p>
<p>--&quot;We project the acquisition will be highly additive to (Dura) earnings beginning in 1997,&quot; Ginsberg said.</p>
<p>-- Chicago Newsdesk 312-408-8787</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-08-22"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
